Franz-Werner Haas
Chief Executive Officer bij Curevac Aktiebolag
Vermogen: 443 986 $ op 31-03-2024
Profiel
Dr. Franz-Werner Haas is een Chief Executive & Operating Officer bij Curevac Aktiebolag, een Chief Executive Officer bij CureVac AG en een Chief Executive Officer bij CureVac NV. Dr. Haas was voorheen werkzaam als Chief Compliance Officer & VP-Operations bij Expedeon AG, General Counsel bij Sirona Dental Systems, Inc. en General Counsel bij Lion Bioscience, Inc. Hij behaalde zijn doctorale graad aan de Universiteit van Edinburgh en een doctorale graad aan de Universitt Saarbrcken.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CUREVAC N.V.
0.07% | 31-03-2023 | 146 530 ( 0.07% ) | 443 986 $ | 31-03-2024 |
Actieve functies van Franz-Werner Haas
| Bedrijven | Functie | Begin |
|---|---|---|
Curevac Aktiebolag
 Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The private company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Chief Executive Officer | 04-08-2020 |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Chief Executive Officer | 19-07-2023 |
Eerdere bekende functies van Franz-Werner Haas
| Bedrijven | Functie | Einde |
|---|---|---|
| CUREVAC N.V. | Chief Executive Officer | 31-03-2023 |
| 2INVEST AG | Compliance Officer | 01-03-2012 |
| SIRONA DENTAL SYSTEMS, INC. | General Counsel | 01-05-2005 |
Lion Bioscience, Inc.
 Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | General Counsel | 01-12-2004 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Executive Officer | - |
Opleiding van Franz-Werner Haas
| The University of Edinburgh | Graduate Degree |
| Universität Saarbrücken | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| 2INVEST AG | Finance |
| CUREVAC N.V. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Sirona Dental Systems, Inc.
 Sirona Dental Systems, Inc. Medical SpecialtiesHealth Technology Sirona Dental Systems, Inc. was developing, manufacturing and marketing dental equipment. Its products include CAD/CAM restoration systems, imaging systems, treatment centers, instruments, and cabinetry. The company was founded on October 1, 1997 and was headquartered in York, PA. | Health Technology |
Lion Bioscience, Inc.
Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Commercial Services |
Curevac Aktiebolag
Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The private company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Process Industries |
LimmaTech Biologics AG
LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Commercial Services |
